| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 06/07/2005 | US6903081 Phosphoramidates and methods therefor |
| 06/07/2005 | US6903079 Nucleoside compounds and compositions thereof |
| 06/07/2005 | CA2098881C Stereoselective glycosylation process |
| 06/07/2005 | CA2074853C 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents |
| 06/02/2005 | WO2005049633A1 Acyl ribonucleosides and acyl deoxyribonucleosides |
| 06/02/2005 | US20050119470 Oligonucleotide sequences for use in treatment and prevention of vision and metabolic disorders; RNA interference |
| 06/02/2005 | US20050119286 Beta-2'-or 3'-halonucleosides |
| 06/02/2005 | US20050119201 Inhibitor of dna methylation |
| 06/02/2005 | US20050119200 Nucleoside derivatives for treating hepatitis C virus infection |
| 06/02/2005 | US20050118706 Polymer arrays |
| 06/02/2005 | US20050118623 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 06/01/2005 | EP1534727A2 Crystalline and amorphous forms of beta-l-2 -deoxythymidine |
| 06/01/2005 | EP1534726A2 Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
| 06/01/2005 | EP1124838B1 Nucleic acid labeling compounds |
| 05/31/2005 | US6900315 2-amino-9H-purin-9-yl compounds and methods for inhibiting/treating HIV infections and AIDS related symptoms |
| 05/31/2005 | US6900309 Aminocarbonylation reaction of a adenosine compound containing purine base and pentofuranosyl sugar and a leaving group at 2 position of purine ring, with an amine compound in presence of carbon monoxide and suitable coupling catalyst |
| 05/31/2005 | US6900308 α-modified nucleoside triphosphates |
| 05/31/2005 | US6900307 Phenylsulfide derivatives with purine nucleic base containing amine or acyl substituent at 2-position of purine ring |
| 05/31/2005 | US6900301 Oligonucleotides for use in human therapeutics an diagnostics |
| 05/31/2005 | US6900298 Process for producing nucleic acid derivative |
| 05/31/2005 | US6900297 A compound which hybridizes with a nucleic acid includes multiple inked nucleosides (inlcudes a pentofuranosyl sugar portion and a base portion), and at least one sugar o-is terminated with R-N(R1a R1b) substitutent |
| 05/31/2005 | US6900180 Mixture of folic acid, vitamin b6 and b12 with carbohydrates, fats and proteins; infant formula; sleep disorders |
| 05/26/2005 | WO2005012323A3 Compounds useful as a3 adenosine receptor agonists |
| 05/26/2005 | WO2004082619A3 Forms of 5-azacytidine |
| 05/26/2005 | US20050113330 Viricides for the treatment of hepatitis B virus infections |
| 05/26/2005 | US20050112784 Analyte assay using particulate labels |
| 05/26/2005 | US20050112676 Solid support comprising a plurality of immobilized, positionally distinguishable, multi-subunit sequence specific reagents for use in characterization and classification of biological samples; immunoaffinity chromatography |
| 05/26/2005 | US20050112563 Sub-sequences of 2'-deoxy-erythro-pentofuranosyl nucleotides that activate RNase H enzyme; diagnostics; antisense therapeutics |
| 05/25/2005 | EP1533317A1 Nucleosides for imaging and treatment applications |
| 05/25/2005 | EP0836613B1 Water-soluble adenosine kinase inhibitors |
| 05/25/2005 | EP0813416B1 Reduction of infarct volume using citicoline |
| 05/25/2005 | CN1620295A Preparation of intermediates useful in the synthesis of antiviral nucleosides |
| 05/25/2005 | CN1202864C Use of CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 05/25/2005 | CN1202824C Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for preparing medicine for treating hepatitis virus infection |
| 05/24/2005 | US6897302 Reacting xylose with acetone in presence of acid catalyst; dehydration; hydrolysis; acylation in presence of basic catalyst; deblocking; halogenation |
| 05/24/2005 | US6897201 Administering a nucleoside 5'-pyrophosphate pyranoside or analogue, of given formula |
| 05/24/2005 | US6896871 For therapy of soft tissues surrounding bone and bone-related diseases, such as bone cancer and osteoporosis |
| 05/24/2005 | CA2227491C In situ preparation of nucleoside phosphoramidites and oligonucleotide synthesis |
| 05/19/2005 | WO2005044836A2 Macromolecular nucleotide compounds and methods for using the same |
| 05/19/2005 | WO2005044835A1 METHODS FOR PREPARING 7-(2'-SUBSTITUTED-ß-D-RIBOFURANOSYL)-4-(NR2R3)-5-(SUBSTITUTED ETHYN-1-YL)-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES |
| 05/19/2005 | WO2005044312A1 Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use |
| 05/19/2005 | WO2004012667A8 Photoactivated anti-viral and anti-cancer agent |
| 05/19/2005 | WO2003093290A8 Nucleoside derivatives for treating hepatitis c virus infection |
| 05/19/2005 | US20050107344 Bi phosphate containing protonated compound with two end groups; disinfecting surfaces of surgical equipments and skin |
| 05/19/2005 | US20050107312 Nucleoside compounds for treating viral infections |
| 05/19/2005 | US20050106658 Remodeling and glycoconjugation of peptides |
| 05/19/2005 | US20050106101 Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use |
| 05/19/2005 | CA2543116A1 Methods for preparing 7-(2'-substituted-.szlig.-d-ribofuranosyl)-4-(nr2r3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives |
| 05/18/2005 | EP1530578A2 Modified nucleotides for polynucleotide sequencing |
| 05/18/2005 | EP0820461B1 Aryl-ester phosphoramidate derivatives of 2',3'-didehydronucleosides |
| 05/18/2005 | CN1617937A Labelled nucleotides |
| 05/18/2005 | CN1617726A N4-acylcytosine nucleosides for treatment of viral infections |
| 05/18/2005 | CN1616671A Natural antitumor or antiviral substances and use of the same |
| 05/18/2005 | CN1616475A Process for preparing cytidine-S'-phosphate |
| 05/18/2005 | CN1616459A Adenosine derivatives |
| 05/18/2005 | CN1202118C Adenosine derivatives |
| 05/18/2005 | CN1202117C Method for preparing sulfated zidovudine (1-4) polysaccharidase |
| 05/17/2005 | US6894159 Process for the preparation of 2′-fluoro-5-methyl-beta-L-arabino-furanosyluridine |
| 05/17/2005 | US6894158 Reacting nucleoside with cyanoethyl-N,N,N',N'-tetraisopropyl-phosphorodiamidite in presence of trifluoroacetic acid-diisopropylethylamine complex |
| 05/17/2005 | US6894032 Or salt thereof |
| 05/17/2005 | US6893815 Nucleobase heterocyclic combinatorialization |
| 05/12/2005 | WO2005042557A1 Method for producing purine compound |
| 05/12/2005 | WO2005042556A1 Nucleoside compounds for treating viral infections |
| 05/12/2005 | WO2005016514A3 Combinatorial synthesis on support |
| 05/12/2005 | WO2004000858A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 05/12/2005 | US20050101776 2' or 3' -deoxy and 2' , 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti-viral agents |
| 05/12/2005 | US20050101765 Photocleavable protecting groups |
| 05/12/2005 | US20050101551 Prevent tissue or organ damage; antiischemic agents |
| 05/12/2005 | US20050101550 Nucleoside compounds for treating viral infections |
| 05/12/2005 | US20050100611 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 05/12/2005 | CA2542776A1 Nucleoside compounds for treating viral infections |
| 05/11/2005 | EP1470114A4 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 05/11/2005 | CN1615314A Phospholipid derivatives of nucleosides as antitumoral medicaments |
| 05/11/2005 | CN1613864A Method for purifying and preparing nucleoside triphosphate derivative |
| 05/10/2005 | US6891033 Labelling compounds for the simple synthesis of 3'-[18F]fluoro-3'-deoxythymidine and a method for the production thereof |
| 05/10/2005 | US6891021 Regulated apoptosis |
| 05/06/2005 | WO2005040185A1 Method for producing 2'-deoxy-2'-fluoropyrimidine nucleosides |
| 05/06/2005 | WO2005040184A1 Process for the preparation of doxifluridine |
| 05/06/2005 | WO2005040183A2 Process for the preparation of fludarabine phosphate |
| 05/06/2005 | WO2005039484A2 Indolocarbazole anticancer agents and methods of using same |
| 05/06/2005 | WO2004090154A3 Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis |
| 05/06/2005 | WO2004078933A3 Intracellular delivery of small molecules proteins and nucleic acids |
| 05/05/2005 | US20050096293 Analogs of nitrobenzylthioinosine |
| 05/05/2005 | US20050095652 Solid support comprising immobilized biopolymers for use as assay in monitoring receptor ligand interaction; drug screening; antibodiy sensitivity |
| 05/05/2005 | US20050095270 Introducing large volumes of therapeutics without hearing loss via round window membrane, semicircular canals, cochleostomy and/or stapes footplate |
| 05/04/2005 | EP1527083A1 Novel adenosine analogues and their use as pharmaceutical agents |
| 05/04/2005 | EP1527082A2 Anti-viral 7-deaza d-nucleosides and uses thereof |
| 05/04/2005 | EP1363928B1 Process for the preparation of (e)-5-(2-bromovinyl)-2'-deoxyuridine |
| 05/04/2005 | CN1612889A 3-b-d-ribofuranosylthiazolo [4, 5-d] pyridimine nucleosides and uses thereof |
| 05/04/2005 | CN1200003C Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
| 05/04/2005 | CN1199981C Zinc scutellarin as a new medicine |
| 05/03/2005 | US6887858 Method of treating dry eye disease with purinergic receptor agonists |
| 05/03/2005 | US6887855 Crystal structure; for treatment of myelodysplastic syndromes |
| 04/28/2005 | WO2005023826A3 Polymorphic nucleoside compounds |
| 04/28/2005 | WO2005014609A3 Method of producing a highly stereoregular phosphorus atom-modified nucleotide analogue |
| 04/28/2005 | WO2003072067A3 Compositions and methods for treating epithelial and retinal tissue diseases |
| 04/28/2005 | US20050090660 2'-deoxy-L-nucleosides |
| 04/28/2005 | US20050090659 phospholipid derivatives preferably of non-natural nucleosides; antitumoral or antiproliferative active ingredients for the prophylaxis and/or curative, palliative or supportive treatment of tumor diseases or neoplasias, such as for example carcinomas, sarcomas, lymphomas or leukemias |
| 04/28/2005 | US20050090463 7-(2'-C-methyl- beta -D-ribofuranosyl)-4-amino-5-(2'-trimethylsilylethyn-1-yl)-pyrrolo[2,3-d]pyrimidine; treating hepatitis C; viricide mixture contains other active drugs |
| 04/28/2005 | US20050090458 Salts of avermectins substituted in the 4"-position and having pesticidal properties |